Covered recipient · General Payments record
PARIVASH MOHAMADI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$6,126.29
- Reported across 226 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $555.55 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $225.90 | 19 |
| Acerta Pharma LLC | $159.16 | 3 |
| Amgen Inc. | $50.87 | 3 |
| Lilly USA, LLC | $31.03 | 1 |
| Otsuka America Pharmaceutical, Inc. | $27.68 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.16 | 1 |
| Abbott Laboratories | $20.62 | 1 |
| Lundbeck LLC | $16.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.62 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124967549 | CMS |
| ABBVIE INC. | $8.33 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050714 | CMS |
| ABBVIE INC. | $8.35 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050716 | CMS |
| ABBVIE INC. | $9.73 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050718 | CMS |
| ABBVIE INC. | $6.36 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050720 | CMS |
| ABBVIE INC. | $7.24 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050722 | CMS |
| ABBVIE INC. | $5.58 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050724 | CMS |
| ABBVIE INC. | $8.50 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050726 | CMS |
| ABBVIE INC. | $7.22 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050728 | CMS |
| ABBVIE INC. | $21.72 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050730 | CMS |
| ABBVIE INC. | $9.02 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050732 | CMS |
| ABBVIE INC. | $7.92 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050734 | CMS |
| ABBVIE INC. | $30.03 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050736 | CMS |
| ABBVIE INC. | $6.86 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050738 | CMS |
| ABBVIE INC. | $15.00 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050740 | CMS |
| ABBVIE INC. | $6.14 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050742 | CMS |
| ABBVIE INC. | $9.44 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050744 | CMS |
| ABBVIE INC. | $27.14 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050746 | CMS |
| ABBVIE INC. | $15.50 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050748 | CMS |
| ABBVIE INC. | $15.82 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050750 | CMS |
| Amgen Inc. | $23.82 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115938534 | CMS |
| Amgen Inc. | $13.59 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115938545 | CMS |
| Amgen Inc. | $13.46 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117632043 | CMS |
| AstraZeneca Pharmaceuticals LP | $111.05 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105547269 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.75 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104452354 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.36 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104207609 | CMS |
| Lilly USA, LLC | $31.03 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135306281 | CMS |
| Lundbeck LLC | $16.13 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145947344 | CMS |
| Otsuka America Pharmaceutical, Inc. | $27.68 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118944397 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.16 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153567080 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.